We have located links that may give you full text access.
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging.
Radiology 1996 September
PURPOSE: To evaluate the enhancement patterns of solitary pulmonary nodules (SPNs) with dynamic contrast-material-enhanced magnetic resonance (MR) imaging to differentiate between benign and malignant SPNs.
MATERIALS AND METHODS: Twenty-eight patients with SPNs 30 mm or smaller in diameter were examined with pre- and postcontrast, electrocardiographically gated, T1-weighted spin-echo (SE) sequences and a snapshot gradient-echo (GRE) sequence after bolus injection of a paramagnetic contrast agent. For all SPNs (20 malignant, eight benign), the percentage increase in signal intensity (%SI) on the postcontrast T1-weighted SE images and the enhancement curves (%SI/sec) for the snapshot GRE measurements were established from regions of interest.
RESULTS: Malignant nodules showed a higher increase of signal intensity during the first transit of the bolus of contrast material on the dynamic snapshot GRE images (malignant: median, 18.1 %SI/sec; range, 6.7-95.2 %SI/sec; benign: median, 2.3 %SI/sec; range, 0.1-8.1 %SI/sec) (P < .0001). Static T1-weighted SE measurements did not allow differentiation between malignant (median, 53.4 %SI; range 12.5-110.0 %SI) and benign (median, 33 %SI; range, 0.8-85.5 %SI) (P > .2) nodules on the basis of the degree of contrast enhancement.
CONCLUSION: Dynamic contrast-enhanced MR measurements of tumor enhancement can provide additional information about the nature of SPNs.
MATERIALS AND METHODS: Twenty-eight patients with SPNs 30 mm or smaller in diameter were examined with pre- and postcontrast, electrocardiographically gated, T1-weighted spin-echo (SE) sequences and a snapshot gradient-echo (GRE) sequence after bolus injection of a paramagnetic contrast agent. For all SPNs (20 malignant, eight benign), the percentage increase in signal intensity (%SI) on the postcontrast T1-weighted SE images and the enhancement curves (%SI/sec) for the snapshot GRE measurements were established from regions of interest.
RESULTS: Malignant nodules showed a higher increase of signal intensity during the first transit of the bolus of contrast material on the dynamic snapshot GRE images (malignant: median, 18.1 %SI/sec; range, 6.7-95.2 %SI/sec; benign: median, 2.3 %SI/sec; range, 0.1-8.1 %SI/sec) (P < .0001). Static T1-weighted SE measurements did not allow differentiation between malignant (median, 53.4 %SI; range 12.5-110.0 %SI) and benign (median, 33 %SI; range, 0.8-85.5 %SI) (P > .2) nodules on the basis of the degree of contrast enhancement.
CONCLUSION: Dynamic contrast-enhanced MR measurements of tumor enhancement can provide additional information about the nature of SPNs.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app